ArticleOphthalmology science

Netarsudil 0.02% Alters Episcleral Venous Flowrates: A Clinical Trial Using Erythrocyte-Mediated Angiography.

Sarah Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.